← Russell 3000 cross-section

MOH MOLINA HEALTHCARE, INC.

Trailing twelve months to 2026-06-30 · as filed 2026-07-23, not restated
Financials

Scale

Market cap
$10.5bn
Revenue TTM
$44.5bn
Net income TTM
$-7m
Free cash flow
$271m
Composite score
27.1
Sector rank
#693

Valuation

P / E
EV / EBITDA
14.3
EV / sales
0.1
FCF yield
2.59%
Earnings yield vs 10-yr
-4.80pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-0.0%
EBITDA margin
0.8%
ROE
-0.2%
ROIC
Revenue growth
2.5%

Insider activity, last 90 days

Net open-market
$0.00m
Buyers
0
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

CONSOLIDATED RESULTS NET INCOME AND OPERATING INCOME Net income in the second quarter of 2026 amounted to $60 million, or $1.19 per diluted share, compared with $255 million, or $4.75 per diluted share, in the second quarter of 2025. Net income in the six months ended June 30, 2026 amounted to $74 million, or $1.46 per diluted share, compared with $553 million, or $10.19 per diluted share, in the six months ended June 30, 2025. Operating income in the six months ended June 30, 2026 decreased to $228 million, compared with $806 million in the six months ended June 30, 2025. …MOLINA HEALTHCARE, INC., 10-Q, period ended 2026-06-30, filed 2026-07-23

Read the full passage →